EP 3846816 A4 20220817 - NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES
Title (en)
NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES
Title (de)
NEUROPROTEKTIVE MITTEL ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
Title (fr)
AGENTS NEUROPROTECTEURS POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
Publication
Application
Priority
- US 201816124974 A 20180907
- US 201816154301 A 20181008
- US 2019049927 W 20190906
Abstract (en)
[origin: WO2020051435A1] A compound having formula I is useful for treating a neurodegenerative disease: (I) or a pharmaceutically acceptable salt or ester thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8 are each independently hydroxyl, C1-4 alkyl, C1-4 alkoxyl, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C4-8, are specified substituents.
IPC 8 full level
A61K 31/495 (2006.01); A61K 31/137 (2006.01); A61K 31/4184 (2006.01); A61K 31/428 (2006.01); A61K 31/496 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 31/137 (2013.01); A61K 31/4184 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01)
Citation (search report)
No further relevant documents disclosed
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2020051435 A1 20200312; CA 3111561 A1 20200312; EP 3846816 A1 20210714; EP 3846816 A4 20220817
DOCDB simple family (application)
US 2019049927 W 20190906; CA 3111561 A 20190906; EP 19858466 A 20190906